Latest AI and machine learning research in schizophrenia for healthcare professionals.
Selecting first-line antipsychotic medication for first episode of psychosis patients is a very challenging task requiring the clinicians to empirically weight multiple criteria. Precision treatment rules developed using health records offer a pragmatic approach to support clinicians' treatment selection, however, they don't incorporate side effects and patient preferences. We used Electronic Heal...
BACKGROUND: Preventing relapses of psychosis is difficult and important. Digital remote monitoring (DRM) systems are being developed and tested to support this. Increasingly, these systems use algorithm-based relapse prediction. Hence, understanding stakeholder views about algorithmic prediction is crucial. Existing qualitative work has explored health professionals' views, but very few studies ha...
Effective management of chemical mixtures presents a continuing challenge due to the growing diversity and inadequate characterization of contaminants...
BACKGROUND: Neurodevelopmental disorders, especially attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), have seen a m...
Pharmacovigilance is vital for post-market drug safety monitoring. Traditional trials inadequately capture adverse reactions. Patient-generated opinio...
Large language models are rapidly becoming embedded in everyday life through artificial intelligence (AI) chatbots that people use for practical assis...
Hallucinations are significant symptoms in psychiatric and neurodegenerative diseases, that may indicate advanced disease progression or worse disease...
Antipsychotic treatment is associated with higher risk of major adverse cardiovascular events (MACEs), and risk may vary by multimorbidity and concomi...
INTRODUCTION: Large language models (LLMs) are increasingly being explored in healthcare, particularly for enhancing patient education. In spine surge...
BACKGROUND: Generative artificial intelligence (AI) chatbots have rapidly entered public use, including in contexts involving emotional support and me...
Plasma proteomic biomarkers hold significant promise for enhancing clinical assessments and improving early detection of psychosis conversion; however...
IMPORTANCE: While growing evidence implicates synaptic dysfunction as a key pathophysiological mechanism in cognitive impairments in schizophrenia (SC...
BACKGROUND: Second-generation antipsychotics (SGAs) are frequently used off-label to manage behavioral symptoms in Alzheimer's disease (AD), despite o...
BACKGROUND: Identifying patients with first-episode psychosis (FEP) at high mortality risk may facilitate personalized treatment regimen development a...
Delusions, including persecutory beliefs, are theorised to arise from multifaceted interacting mechanisms. In our previous machine-learning study, 55 ...
Schizophrenia (SCZ) is a complex psychiatric disorder, and its pathogenic mechanisms are not yet fully understood. The identification of reliable bloo...
OBJECTIVE: To develop and validate a multi-lead electrocardiogram (ECG)-based machine learning system for automated classification of major psychiatri...
BACKGROUND: Identifying patients with first-episode psychosis (FEP) who are unlikely to achieve early clinical recovery (ECR) is critical for personal...
PURPOSE: The purpose of this study was to review the accuracy of 4 different artificial intelligence (AI) tools in providing dosing recommendations fo...